Market Overview

Oppenheimer Reiterates Outperform on Mindray Medical International


Oppenheimer reiterated its Outperform rating on Mindray Medical International (NYSE: MR). At the moment, Oppenheimer has a price target of $32 placed on the company's stock. On Friday, Mindray added 4.35% to its value to finish the day at $29.27.


Related Articles (MR)

View Comments and Join the Discussion!

Posted-In: Mindray Medical OppenheimerReiteration Analyst Ratings

Latest Ratings

DEWilliam BlairUpgrades
SIXGoldman SachsInitiates Coverage On
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at